Market Overview:
The global nocturia market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of nocturia, rising geriatric population, and growing awareness about available treatment options. The global nocturia market is segmented on the basis of type into anticholinergic drugs, desmopressin, antibiotics, antispasmodic drugs, and others. The desmopressin segment is expected to grow at a CAGR of 6.1% during the forecast period from 2018 to 2030. This growth can be attributed to the increasing use of desmopressin for treating nocturia caused by diabetes mellitus and other conditions. On the basis of application, the global nocturia market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others segments. The hospital pharmacies segment accounted for majority share in 2017 and is projected to maintain its dominance duringthe forecast period from 2018to2030 owingto increase in numberof patients with Nocturia seeking medical assistancefrom hospitalsand clinics acrossthe globe .
Product Definition:
Nocturia is a condition where a person has to wake up frequently at night to urinate. It can be caused by many things, such as drinking too much fluids before bed, having a bladder infection, or being pregnant. Nocturia can lead to fatigue and difficulty concentrating during the day.
Anticholinergic Drugs:
Anticholinergic drugs are the substances that block the action of acetylcholine, a chemical messenger that facilitates information transfer in the brain and nervous system. Anticholinergic drug use is associated with side effects such as dry mouth, blurred vision, difficulty in swallowing and increased heart rate.
Desmopressin:
Desmopressin is a drug that reduces the amount of time it takes for your body to get the message that you have had enough water. It works by reducing the amount of free water in your body and hence prevents night time urination. It is used as an anti-epileptic drug, which means it helps to prevent or reduce seizures caused by epilepsy, which is why some people also call it an anticonvulsant.
Application Insights:
Based on application, the global nocturia market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacy held the largest share of over 70% in 2017. Nocturia is more common among hospitalized patients as they are at higher risk for developing urinary tract infections (UTIs). As a result, pharma companies have developed various products to treat this condition including desmopressin acetate nasal spray which can be used by patients who are admitted to hospitals or sleepover hostsels.
The online pharmacy segment is expected to witness significant growth during the forecast period owing to several advantages offered such as convenience and flexibility along with cost-effectiveness and transparency that cannot be matched by traditional brick-and-mortar dispensing methods. Moreover, increasing internet usage rates coupled with easy access from different parts of the world will further boost industry growth during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of CVDs, diabetes, and cancer among others. Thus, patients suffering from these chronic conditions are more prone to Nocturia and require treatment for excessive urination at night time. In addition, growing awareness about nocturnal urine drainage in North America is also one of the key factors responsible for regional market growth.
Asia Pacific is anticipated to be fastest-growing region over the forecast period owing to rising geriatric population.
Growth Factors:
- Rising geriatric population: The global geriatric population is expected to grow at a CAGR of 5.0% from 2016 to 2020, and this will lead to an increase in the prevalence of Nocturia.
- Increasing awareness about Nocturia: There is a growing awareness among people about the symptoms and treatment options for Nocturia, which is likely to drive the market growth.
- Growing demand for minimally invasive procedures: The demand for minimally invasive procedures such as laser therapy and surgery is increasing due to their less-invasive nature and shorter recovery time as compared to traditional surgical procedures. This will boost the growth of the Nocturia market during the forecast period.
- Technological advancements in diagnostic devices: Technological advancements in diagnostic devices such as ultrasound machines, CT scanners, MRI scanners, etc., are helping physicians detect various causes of Nocturia more accurately than ever before, thereby driving market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nocturia Market Research Report
By Type
Anticholinergic Drugs, Desmopressin, Antibiotics, Antispasmodic, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Allergan, Urigen Pharmaceuticals, Ferring Pharmaceuticals, Glenmark Pharmaceuticals, Teva Pharmaceutical Industries, AA Pharma, Avadel Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
195
Number of Tables & Figures
137
Customization Available
Yes, the report can be customized as per your need.
Global Nocturia Market Report Segments:
The global Nocturia market is segmented on the basis of:
Types
Anticholinergic Drugs, Desmopressin, Antibiotics, Antispasmodic, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Urigen Pharmaceuticals
- Ferring Pharmaceuticals
- Glenmark Pharmaceuticals
- Teva Pharmaceutical Industries
- AA Pharma
- Avadel Pharmaceuticals
Highlights of The Nocturia Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anticholinergic Drugs
- Desmopressin
- Antibiotics
- Antispasmodic
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nocturia Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nocturia is the term used to describe a person's tendency to have frequent urination during the night. Nocturnal urination can be due to a number of different reasons, including an increase in fluid intake or activity at night, stress, and medication side effects.
Some of the major players in the nocturia market are Allergan, Urigen Pharmaceuticals, Ferring Pharmaceuticals, Glenmark Pharmaceuticals, Teva Pharmaceutical Industries, AA Pharma, Avadel Pharmaceuticals.
The nocturia market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nocturia Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nocturia Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nocturia Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nocturia Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nocturia Market Size & Forecast, 2020-2028
4.5.1 Nocturia Market Size and Y-o-Y Growth
4.5.2 Nocturia Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Anticholinergic Drugs
5.2.2 Desmopressin
5.2.3 Antibiotics
5.2.4 Antispasmodic
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nocturia Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nocturia Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Anticholinergic Drugs
9.6.2 Desmopressin
9.6.3 Antibiotics
9.6.4 Antispasmodic
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Anticholinergic Drugs
10.6.2 Desmopressin
10.6.3 Antibiotics
10.6.4 Antispasmodic
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Anticholinergic Drugs
11.6.2 Desmopressin
11.6.3 Antibiotics
11.6.4 Antispasmodic
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Anticholinergic Drugs
12.6.2 Desmopressin
12.6.3 Antibiotics
12.6.4 Antispasmodic
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Anticholinergic Drugs
13.6.2 Desmopressin
13.6.3 Antibiotics
13.6.4 Antispasmodic
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nocturia Market: Competitive Dashboard
14.2 Global Nocturia Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Urigen Pharmaceuticals
14.3.3 Ferring Pharmaceuticals
14.3.4 Glenmark Pharmaceuticals
14.3.5 Teva Pharmaceutical Industries
14.3.6 AA Pharma
14.3.7 Avadel Pharmaceuticals
